Factory Supply 99% Purity Weight Loss GLP-1 Peptides 10mg Tirzepatide Lyophilized Peptides

• Powder: Yes
• Customized: Non-Customized
• State: Solid
• Purity: >98%
• Shipping: FedEx TNT UPS DHL
• Shelf Time: 2 Years
• Model NO.: CAS 2023788-19-2
• Stock: Yes
• Color: White Peptides
• Samples: Available
• Transport Package: Al-Foil Bag
• Specification: 1bags
• Trademark: HHD
• Origin: China
• Production Capacity: 1000bags

Product Description

 

WE ARE MANUFACTURER!
Factory supply, Higher quality, Lower Price!!

High Purity GIP GLP-1 peptides Tirzepatide 5mg 10mg 15mg Stock CAS:2023788-19-2

 
Product Information:
Products Name:Tirzepatide
CAS No.: 2023788-19-2
Purity: 99.0%min.(HPLC)
Molecular Formula: C225H348N48O68  
Molecular Weight: 4813.45g/mol
Sequence: Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{diacid-gamma-Glu-(AEEA)2-Lys}-AFVQWLIAGGPSSGAPPPS-NH2
Appearance: White Lyophilized powder
Storage:After reconstitution store at 2°C - 8°C
 

 

Description:

Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity. 

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.
Once-weekly injectable semaglutide, a selective GLP-1 receptor agonist, is approved for the treatment of type 2 diabetes at doses up to 1 mg. In trials involving patients who received semaglutide, the mean reductions in the glycated hemoglobin level have been reported to be as high as 1.8 percentage points and the mean reductions in body weight have been reported to be as high as 6.5 kg.
We conducted the SURPASS-2 trial (A Study of Tirzepatide [LY3298176] versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants with Type 2 Diabetes) to compare the efficacy and safety of tirzepatide at doses of 5 mg, 10 mg, and 15 mg with those of semaglutide at a dose of 1 mg in patients with type 2 diabetes that had been inadequately controlled with metformin monotherapy.


Rybelss (semaglutide) is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Rybelss is usually given after other diabetes medicines have been tried without success.

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.

Weekly semaglutide 2.4 mg (Wegoy, Novo Nordisk), a GLP-1 receptor agonist, is the first-approved drug for chronic weight management in adults with general obesity or overweight since 2014. Semaglutide is indicated for chronic weight management in adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity, such as type 2 diabetes or hypertension, or in adults with a BMI of at least 30 kg/m²

Semaglutide 1 mg injection (Ozempc) was first approved as a treatment for type 2 diabetes in 2017.

Safety and efficacy of semaglutide 2.4 mg was assessed in four 68-week trials. Three were randomized, double-blind, placebo-controlled trials, including 16 weeks of dose increases, and one was a double-blind, placebo-controlled, randomized withdrawal trial in which patients assigned semaglutide either continued treatment or switched to a placebo

Semaglutide 2.4 mg should not be used in combination with other semaglutide-containing products, other GLP-1 receptor agonists or other products intended for weight loss, including prescription drugs, over-the-counter drugs and herbal products, according to the release. Semaglutide 2.4 mg has not been studied in patients with a history of pancreatitis.

This is a once-weekly injectable, which is more tolerable way of managing obesity vs. other treatments. The STEP study data showed semaglutide 2.4 mg crosses the magic threshold of 10% weight loss for many people who received it. This is another tool that will allow clinicians to better manage obesity.

Function

• Diabetes Type 2 Medicine
• Oral GLP-1RA Medication
• Weight Loss
• Diabetes Mellitus
• Obesity
• Diabetic Coma (in DM Type II)
• Diabetic Ketoacidosis (in DM Type II)
• Cardiovascular Risk Reduction

 

 

Nootropics Supplement product list 

 

Category	Products
	Name	Cas
warehouse available	Tianeptine free acid	66981-73-5
	Tianeptine sodium	30123-17-2
	Tianeptine sulfate	1224690-84-9
Nootropics&Supplements	Noopept	157115-85-0
	NSI-189	1270138-40-3
	Piracetam	7491-74-9
	NSI189 phosphate	1270138-41-4
	Oxiracetam	62613-82-5
	Phenibut	1078-21-3
	Pirfenidone	53179-13-8
	Pramiracetam	68497-62-1
	AC262,356/536	870888-46-3
	ACP-105	899821-23-9
	99% Alpha GPC	28319-77-9
	Coluracetam	135463-81-9
	PRL-8-53	51352-87-5
	Sunifiram	314728-85-3
	Eria Jarensis
	N-Phenethyl Dimethylamin
	NRC/ (Nicotinamide Riboside) Chloride	23111-00-4
	NMN (β-Nicotinamide Mononucleotide)	1094-61-7
	Yohimbine hydrochloride	65-19-0
	Huperzine A	120786-18-7
	Citicoline sodium	33818-15-4
	Tyrosine	60-18-4
	J147	1146963-51-0
	Ginkgo Biloba	90045-36-6
	Uridine-5' -Monophosphate	58-97-9
	Ginkgo Biloba Extract	90045-36-6
	Bacopa Monnieri	/
	beta ecdysterone	5289-74-7
	mk67	159752-10
	Pyrroloquinoline quinone(PQQ)	72909-34-3

Packaging & Shipping

Our service

1.COA/MSDS/ROS/MOA Available.
2.Any inquiries will be replied within 12 hours.
3. Dedication to quality, supply & service.
4.Strictly on selecting raw materials.
5.Reasonable & competitive price, fast lead time.
6.Faster delivery:Sample order in stock and one week  for bulk production.
7.We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
8.Timely after-service resolves your worry for internation trade.
9.Payment: